Avadel Pharmaceuticals PLC
AVDL18.830USD
+0.130+0.70%
收盤 11/11, 16:00（美東）報價延遲15分鐘
1.83B總市值
虧損本益比TTM
關於 Avadel Pharmaceuticals PLC 公司
Avadel Pharmaceuticals PLC 是一家生物製藥公司。該公司的產品 LUMRYZ 是一種緩釋型羥基丁酸鈉，適用於睡前服用一次，用於治療成人發作性睡病患者的猝倒症或白天過度嗜睡 (EDS)。該公司的方法包括將解決方案應用於藥物開發，以解決患者面臨的治療選擇問題。該公司的藥物輸送技術包括 MICROPUMP、LIQUITIME 和 MEDUSA。其 MICROPUMP 技術可用於開發緩釋型固體口服劑型藥物。其 LIQUITIME 技術可用於開發液體懸浮液劑型的緩釋型口服產品，這可能使此類劑型特別適合兒童和/或吞嚥藥片或膠囊有困難的患者。其 MEDUSA 技術可用於開發緩釋型注射劑型藥物。
Avadel Pharmaceuticals PLC簡介
公司代碼AVDL
公司名稱Avadel Pharmaceuticals PLC
上市日期Jan 16, 1952
CEOMr. Gregory J. (Greg) Divis, Jr.
員工數量188
證券類型Ordinary Share
年結日Jan 16
公司地址Block 10-1 Blanchardstown Corporate Park
城市DUBLIN
上市交易所NASDAQ Global Market Consolidated
國家Ireland
郵編15
電話35319015201
網址https://www.avadel.com/
公司代碼AVDL
上市日期Jan 16, 1952
CEOMr. Gregory J. (Greg) Divis, Jr.
Avadel Pharmaceuticals PLC公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Eric J. Ende, M.D.
Dr. Eric J. Ende, M.D.
Independent Director
Independent Director
219.90K
+5.27%
Mr. Peter J. Thornton
Mr. Peter J. Thornton
Independent Director
Independent Director
115.06K
+10.57%
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Independent Director
Independent Director
89.03K
+14.10%
Mr. Thomas S. Mchugh
Mr. Thomas S. Mchugh
Chief Financial Officer
Chief Financial Officer
87.80K
-12.55%
Ms. Linda S. Palczuk
Ms. Linda S. Palczuk
Independent Director
Independent Director
78.90K
+16.20%
Ms. Susan Rodriguez
Ms. Susan Rodriguez
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jerad Seurer
Mr. Jerad Seurer
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
--
--
Mr. Gregory J. (Greg) Divis, Jr.
Mr. Gregory J. (Greg) Divis, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Naseem Amin, M.D.
Dr. Naseem Amin, M.D.
Independent Director
Independent Director
--
--
Ms. Courtney Turiano
Ms. Courtney Turiano
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Eric J. Ende, M.D.
Dr. Eric J. Ende, M.D.
Independent Director
Independent Director
219.90K
+5.27%
Mr. Peter J. Thornton
Mr. Peter J. Thornton
Independent Director
Independent Director
115.06K
+10.57%
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Dr. Mark Anthony Mccamish, M.D., Ph.D.
Independent Director
Independent Director
89.03K
+14.10%
Mr. Thomas S. Mchugh
Mr. Thomas S. Mchugh
Chief Financial Officer
Chief Financial Officer
87.80K
-12.55%
Ms. Linda S. Palczuk
Ms. Linda S. Palczuk
Independent Director
Independent Director
78.90K
+16.20%
Ms. Susan Rodriguez
Ms. Susan Rodriguez
Chief Operating Officer
Chief Operating Officer
--
--
收入明細
單位: USD更新時間: 3月3日 週一
單位: USD更新時間: 3月3日 週一
FY2020
FY2019
業務USD
名稱
營收
佔比
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
地區USD
名稱
營收
佔比
United States
22.33M
100.00%
Ireland
0.00
0.00%
業務
地區
業務USD
名稱
營收
佔比
Vazculep
10.43M
46.70%
Akovaz
9.54M
42.74%
Bloxiverz
2.20M
9.85%
Other
159.00K
0.71%
股東統計
更新時間: 11月11日 週二
更新時間: 11月11日 週二
持股股東
股東類型
持股股東
持股股東
佔比
Janus Henderson Investors
11.40%
Brandes Investment Partners, L.P.
6.64%
Two Seas Capital LP
6.30%
BlackRock Institutional Trust Company, N.A.
6.12%
The Vanguard Group, Inc.
5.66%
其他
63.88%
持股股東
持股股東
佔比
Janus Henderson Investors
11.40%
Brandes Investment Partners, L.P.
6.64%
Two Seas Capital LP
6.30%
BlackRock Institutional Trust Company, N.A.
6.12%
The Vanguard Group, Inc.
5.66%
其他
63.88%
股東類型
持股股東
佔比
Investment Advisor
31.44%
Investment Advisor/Hedge Fund
29.01%
Hedge Fund
24.24%
Individual Investor
4.79%
Venture Capital
3.44%
Research Firm
1.32%
Pension Fund
0.51%
Bank and Trust
0.36%
Insurance Company
0.03%
其他
4.85%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
382
84.18M
86.25%
-22.86M
2025Q2
375
87.44M
90.23%
-20.44M
2025Q1
377
85.31M
88.05%
-24.78M
2024Q4
354
86.56M
89.59%
-16.46M
2024Q3
334
81.87M
84.98%
-15.41M
2024Q2
299
81.11M
84.30%
-2.77M
2024Q1
258
76.98M
80.25%
+5.42M
2023Q4
226
62.92M
70.15%
-3.93M
2023Q3
220
60.11M
69.62%
-5.86M
2023Q2
213
57.67M
66.98%
-1.24M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Janus Henderson Investors
11.13M
11.46%
-2.46M
-18.10%
Jun 30, 2025
Brandes Investment Partners, L.P.
6.49M
6.68%
+820.47K
+14.48%
Jun 30, 2025
Two Seas Capital LP
6.16M
6.34%
+1.21M
+24.43%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.98M
6.16%
+1.29M
+27.56%
Jun 30, 2025
The Vanguard Group, Inc.
5.54M
5.71%
+1.66M
+42.73%
Jun 30, 2025
Tontine Asset Management, LLC
5.18M
5.33%
-950.54K
-15.51%
Jun 30, 2025
Polar Capital LLP
4.00M
4.12%
-356.63K
-8.19%
Jun 30, 2025
Kotler (Kevin)
3.72M
3.83%
-1.01M
-21.37%
Feb 12, 2024
Vivo Capital, LLC
2.68M
2.76%
--
--
Jun 30, 2025
Wealth Effects LLC
2.35M
2.43%
-14.30K
-0.60%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Invesco Pharmaceuticals ETF
2.75%
Innovator IBD 50 Fund ETF
2.64%
iShares Neuroscience and Healthcare ETF
2.45%
SPDR S&P Pharmaceuticals ETF
1.82%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.37%
iShares U.S. Pharmaceuticals ETF
0.55%
Janus Henderson Small/Mid Cap Growth Alpha ETF
0.36%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.19%
JPMorgan Fundamental Data Science Small Core ETF
0.16%
Invesco Nasdaq Biotechnology ETF
0.15%
查看更多
Invesco Pharmaceuticals ETF
佔比2.75%
Innovator IBD 50 Fund ETF
佔比2.64%
iShares Neuroscience and Healthcare ETF
佔比2.45%
SPDR S&P Pharmaceuticals ETF
佔比1.82%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.37%
iShares U.S. Pharmaceuticals ETF
佔比0.55%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比0.36%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.19%
JPMorgan Fundamental Data Science Small Core ETF
佔比0.16%
Invesco Nasdaq Biotechnology ETF
佔比0.15%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
